<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01642992</url>
  </required_header>
  <id_info>
    <org_study_id>2010-11-060</org_study_id>
    <nct_id>NCT01642992</nct_id>
  </id_info>
  <brief_title>Korean Coronary Bifurcation Stenting (COBIS) Registry II</brief_title>
  <official_title>Korean Coronary Bifurcation Stenting (COBIS) Registry II</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hyeon-Cheol Gwon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Samsung Medical Center</source>
  <brief_summary>
    <textblock>
      The COBIS II registry is a multi-center, real-world registry of drug-eluting stenting in
      coronary bifurcation lesions in South Korea. From 18 major coronary intervention centers in
      Korea, a total of 2,873 patients were enrolled in this database between January 2003 and
      December 2009.

      The aim of the study was to investigate long-term clinical results and predictors of adverse
      outcomes after percutaneous coronary intervention with drug-eluting stents for coronary
      bifurcation lesions in South Korea.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2011</start_date>
  <completion_date type="Actual">April 2012</completion_date>
  <primary_completion_date type="Actual">April 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of the composite outcomes of cardiac death, target vessel-related myocardial infarction, or target-lesion revascularization</measure>
    <time_frame>3 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cardiac death</measure>
    <time_frame>3 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Myocardial infarction</measure>
    <time_frame>3 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Target lesion revascularization</measure>
    <time_frame>3 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stent thrombosis</measure>
    <time_frame>3 years</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">2873</enrollment>
  <condition>Coronary Bifurcation Lesion</condition>
  <arm_group>
    <arm_group_label>Coronary bifurcation lesion</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with coronary bifurcation lesion treated with drug-eluting stents
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age &gt;= 18 years

          -  Any type of bifurcation lesion in major epicardial artery

          -  Side branch reference diameter &gt;= 2.3 mm and at least stentable with 2.5 mm stent

          -  Treated with drug-eluting stent

        Exclusion Criteria:

          -  Protected left main disease previous CABG for LAD or LCX territory

          -  Cardiogenic Shock

          -  History of CPR in the same hospitalization
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Samsung Medical Center</name>
      <address>
        <city>Seoul</city>
        <zip>135-710</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>January 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 15, 2012</study_first_submitted>
  <study_first_submitted_qc>July 15, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 17, 2012</study_first_posted>
  <last_update_submitted>January 9, 2013</last_update_submitted>
  <last_update_submitted_qc>January 9, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 10, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Samsung Medical Center</investigator_affiliation>
    <investigator_full_name>Hyeon-Cheol Gwon</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Coronary bifurcation lesion</keyword>
  <keyword>Drug-eluting stent</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

